# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-21-009065
Filing Date
2021-01-29
Accepted
2021-01-29 08:05:02
Documents
29
Period of Report
2021-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm214487d1_8k.htm | 8-K | 54804
2 | EXHIBIT 2.1 | tm214487d1_ex2-1.htm | EX-2.1 | 673287
3 | EXHIBIT 3.1 | tm214487d1_ex3-1.htm | EX-3.1 | 89596
4 | EXHIBIT 10.1 | tm214487d1_ex10-1.htm | EX-10.1 | 305023
5 | EXHIBIT 10.2 | tm214487d1_ex10-2.htm | EX-10.2 | 134173
6 | EXHIBIT 99.1 | tm214487d1_ex99-1.htm | EX-99.1 | 21388
7 | EXHIBIT 99.2 | tm214487d1_ex99-2.htm | EX-99.2 | 29187
8 | GRAPHIC | image_001.jpg | GRAPHIC | 15886
9 | GRAPHIC | tm214487d1_ex99-2img003.jpg | GRAPHIC | 110543
10 | GRAPHIC | tm214487d1_ex99-2img004.jpg | GRAPHIC | 319759
11 | GRAPHIC | tm214487d1_ex99-2img005.jpg | GRAPHIC | 120866
12 | GRAPHIC | tm214487d1_ex99-2img006.jpg | GRAPHIC | 234156
13 | GRAPHIC | tm214487d1_ex99-2img007.jpg | GRAPHIC | 201894
14 | GRAPHIC | tm214487d1_ex99-2img008.jpg | GRAPHIC | 221134
15 | GRAPHIC | tm214487d1_ex99-2img009.jpg | GRAPHIC | 185234
16 | GRAPHIC | tm214487d1_ex99-2img010.jpg | GRAPHIC | 209440
17 | GRAPHIC | tm214487d1_ex99-2img011.jpg | GRAPHIC | 223339
18 | GRAPHIC | tm214487d1_ex99-2img012.jpg | GRAPHIC | 170583
19 | GRAPHIC | tm214487d1_ex99-2img013.jpg | GRAPHIC | 169278
20 | GRAPHIC | tm214487d1_ex99-2img014.jpg | GRAPHIC | 143219
21 | GRAPHIC | tm214487d1_ex99-2img015.jpg | GRAPHIC | 159802
22 | GRAPHIC | tm214487d1_ex99-2img016.jpg | GRAPHIC | 165024
23 | GRAPHIC | tm214487d1_ex99-2img017.jpg | GRAPHIC | 105811
24 | GRAPHIC | tm214487d1_ex99-2img018.jpg | GRAPHIC | 112976
25 | GRAPHIC | tm214487d1_ex99-2img019.jpg | GRAPHIC | 152176
26 | GRAPHIC | tm214487d1_ex99-2img020.jpg | GRAPHIC | 124206
27 | GRAPHIC | tm214487d1_ex99-2img021.jpg | GRAPHIC | 153737
28 | GRAPHIC | tm214487d1_ex99-2img022.jpg | GRAPHIC | 92688
29 | GRAPHIC | tm214487d1_ex99-2img023.jpg | GRAPHIC | 35342
| Complete submission text file | 0001104659-21-009065.txt |  | 6032524

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 21568231
SIC: 2834 Pharmaceutical Preparations